Pharmacovigilance and Drug Safety Software Market Set – About Your Online Magazine


Pharmacovigilance and drug safety software market

Pharmacovigilance and drug safety software market

The drug safety and pharmacovigilance software market is expected to reach $292.97 Mn in 2027 from $160.67 Mn in 2019. The market is expected to grow with a CAGR of 7.6% from 2020-2027 .

The scope of the drug safety and pharmacovigilance software market includes software type, product type, end user, and region. The region-based drug safety and pharmacovigilance software market is segmented into North America, Europe, Asia-Pacific, Middle East and Africa, and South and Central America. The report provides insights and in-depth analysis of the Pharmacovigilance and Drug Safety Software market, emphasizing various parameters such as market trends, technological advances, market dynamics, and analysis of the competitive landscape of key market players around the world. It also includes the COVID-19 impact analysis in all regions.

Request sample pages of this research study at – https://www.theinsightpartners.com/sample/TIPHC00002557/?source=openpr-10425

Prominent / emerging participants in pharmacovigilance and drug safety software market research include:

Veeva Systems
IQVIA Inc.
Ennov
AB Cube
United Biosource LLC
ArisGlobal LLC
Sparta Systems
Oracle Corporation
Sarjen Systems Pvt. Ltd
EXTEND
Maxapplication
Online Business Apps, Inc.

By software type

Fully Integrated Software
Adverse Event Reporting Software
Drug Safety Audit Software
problem tracking software

By delivery mode

cloud based
on premise

By end user

Contract Research Organizations
Pharmaceutical and Biotechnology Companies
Business Process Outsourcing

Pharmacovigilance is the process of monitoring and evaluating adverse drug reactions and is a key component of effective drug regulatory systems, clinical practice, and public health programs. The number of reported adverse drug reactions (ADRs) resulted in an increase in the volume of data handled. In the current global network of pharmacovigilance centers coordinated by the Uppsala Monitoring Center. Pharmacovigilance is a critical and integral part of clinical research and is currently growing in many countries.

Request a copy of this research study at – https://www.theinsightpartners.com/buy/TIPHC00002557/?source=openpr-10425

ABOUT US:

The Insight Partners is an industry research provider of actionable solutions. We help our clients find solutions to their research needs through our syndicated research and consulting services. We specialize in industries such as Semiconductors & Electronics, Aerospace & Defense, Automotive & Transportation, Biotechnology, Healthcare IT, Manufacturing & Construction, Medical Devices, Technology, Media & Telecommunications, Chemicals & Materials.

Contact Us:

If you have any questions about this report or would like more information, please contact us:

North America: +1 646 491 9876

Asia-Pacific: +91 20 6727 8686

Email: sales@theinsightpartners.com

This release was published on openPR.

Paula Fonseca